ENG and melanoma: Another approach was used in our group, using GET of plasmid DNA encoding shRNA against endoglin (pU6-antiCD105), which was demonstrated to be effective in the knockdown of endoglin on endothelial cells in vitro (approximately 50% knockdown) and the B16F10-luc melanoma model in vivo (approximately 80% knockdown) [18,27].